3300 MARINA BOULEVARD, BRISBANE, CA, UNITED STATES, 94005
国家
美国
上市日期
2024-06-12
财年截止
十二月
流通股数
1.07亿
CIK
0002017526
官方网址
--
Freenome Holdings, Inc. 是一家生物技术公司,专注于利用人工智能和多组学技术开发用于早期癌症检测的血液检测。公司总部位于加利福尼亚州布里斯班。
财务指标
--
常见问题
FRNM stock represents shares of a publicly traded company, but the specific business and sector should be verified on the FRNM quote page. Investors can review the company profile, exchange listing, and recent filings to understand what FRNM does and how its shares trade.
Recent performance for FRNM, including daily moves, weekly changes, and longer-term trends, is shown in the price chart and performance table on this page. Because prices change during trading, use the latest FRNM quote and historical return figures rather than a fixed number.
Whether FRNM looks overvalued or undervalued depends on its current price relative to earnings, sales, book value, and peers. Check the latest FRNM valuation metrics on this page and compare them with industry averages and the company's own history before drawing conclusions.
FRNM shares can generally be bought through a brokerage account by placing a market or limit order during regular trading hours. Confirm the exact ticker, exchange, order type, and any commissions before submitting a trade, and review the latest FRNM quote first.
Dividend information for FRNM, including whether it pays dividends and on what schedule, is best confirmed on the dividends section of this page. If FRNM does not pay a dividend, that may reflect a decision to reinvest profits in the business.
Risks for FRNM can include sector-specific competition, customer concentration, regulatory changes, leverage, and sensitivity to economic conditions. Review the company's risk disclosures and the latest FRNM financial statements to understand which risks are most relevant.